DVELA-LEVITT LAB
Bar-Ilan University
Outsmarting Protein Traffic

Lab Research Areas

The lab studies the cellular network of protein trafficking, an essential process required for the proper functioning of all cells and systems of the human body. Dysfunction of the trafficking machinery leads to cellular “traffic jams,” a hallmark of many devastating diseases such as diabetes, cancer, Alzheimer’s disease, and cystic fibrosis.

They hope to find ways to relieve theses traffic jams and look for possible therapeutics to clear the traffic jams out of the cell.

Moran_Dvella-Levitt_Lab_Members

Scholar Profile

Moran Dvela-Levitt joined the Faculty of Life Sciences at Bar-Ilan University after a PhD in Basic Medical Sciences in the Department of Medical Neurobiology, Institute for Medical Research-Israel-Canada at The Hebrew University; and a postdoc at the Kidney Disease Initiative, The Broad Institute of MIT and Harvard and the Department of Medicine, Harvard Medical School at Brigham and Women’s Hospital.

In her lab, Dr. Dvela-Levitt studies the cellular network of protein trafficking, an essential process required for the proper functioning of all cells and systems of the human body. Dysfunction of the trafficking machinery leads to cellular “traffic jams,” a hallmark of many devastating diseases, such as diabetes, cancer, Alzheimer’s disease, and cystic fibrosis. Using high-content imaging techniques, Dr. Dvela-Levitt aspires to learn more about protein trafficking machineries and to identify new therapeutic strategies. The lab initiated funding for a new Opera Phenix High Contend Screening System, a platform that facilitates High Content imaging, used for drug and genetic screens, as well as other applications.

Principal Investigator
Dr. Moran Dvela-Levitt
Zuckerman Faculty Scholar
Established 2020